Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price ...
Acelyrin (NASDAQ:SLRN) stock in focus as the company adopts a poison pill to counter rapid stock acquisition by Tang Capital Partners. Read more here.
In a report released today, Jeff Jones from Oppenheimer reiterated a Buy rating on Alumis Inc. (ALMS – Research Report), with a price target of ...
As Muslims observe Ramadan, cybercriminals are taking advantage of the season of goodwill, launching a wave of scams ...
More than 220,000 people have been trafficked to Southeast Asia and forced to scam people around the world. Funding cuts to ...
Deputy Minister of Vocational Education Nalin Hewage has proposed relocating toque monkeys to an island and feeding them ...
HC Wainwright reissued their buy rating on shares of Alumis (NASDAQ:ALMS – Free Report) in a report published on Monday,Benzinga reports. They currently have a $19.00 price objective on the stock. A ...
Mehboob Hussain was riding the train home on Tuesday when the tracks under the front car exploded. In the depths of central ...
Friday marks three weeks since Pope Francis was hospitalized for bronchitis, which then led to double pneumonia.